Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

3 Trades On Anthem Stock Ahead Of The Healthcare Giant's Q4 Report

By (Tezcan Gecgil/ )Stock MarketsJan 19, 2022 13:19
3 Trades On Anthem Stock Ahead Of The Healthcare Giant's Q4 Report
By (Tezcan Gecgil/ )   |  Jan 19, 2022 13:19
Saved. See Saved Items.
This article has already been saved in your Saved Items
  • Health benefits group Anthem’s stock price is down more than 3.5% in 2022.
  • ANTM stock is likely to stay volatile as management prepares to release Q4 earnings on Jan. 26.
  • Long-term investors could consider buying the dip, especially if shares decline toward $430.

Investors in the health benefits giant Anthem (NYSE:ANTM) have enjoyed returns of 36.9% in the past 12 months. However, the new year has started on a more subdued note for ANTM—the stock is down 3.6%.

Anthem Weekly Chart.
Anthem Weekly Chart.

By comparison, the Dow Jones US Health Care Providers Index returned 18.2% in the past year, but has declined 6.4% year-to-date. Meanwhile, the Dow Jones US Insurance Index is up 31.5% in the past 52 weeks, and has returned 3.4% YTD.

On Dec. 30, ANTM shares went above $470 to hit a record high. But since then, shares have lost close to 5%. Anthem stock’s 52-week range has been $286.04 - $470.02, while the market capitalization stands at $108.4 billion.

Anthem, which provides health insurance, serves around 117 million people. It is one of the largest for-profit, managed healthcare companies in the US.

Management issued robust Q3 financials in late October. Operating revenue was $35.5 billion, up 16% year-over-year. Adjusted EPS came in at $6.79 vs. $4.20 achieved in Q3 2020. Cash and equivalents totaled almost $5.5 billion.

On the results, CEO Gail Boudreaux said:

"The strong growth we saw across all of our benefits business in the third quarter demonstrates that our core offerings, as well as additional innovative products and services, continue to resonate in the market.”

During the quarter, Anthem repurchased 1.2 million shares for $450 million. The weighted average price was $378.85. Meanwhile, management now expects adjusted EPS for 2021 to exceed $25.85. The health insurer is set to release its Q4 numbers on Jan. 26 before the open.

Prior to the release of Q3 metrics, ANTM stock was trading shy of $400. Then came the record high of $470.02 on Dec. 30. Now, Anthem shares are around $447.10, while the current price supports a dividend yield of 1.02%.

What To Expect From Anthem Stock

Among 26 analysts polled via, ANTM stock has an “outperform" rating.

Consensus Estimates of Analysts Polled By
Consensus Estimates of Analysts Polled By


Analysts also have a 12-month median price target of $479.21 for the stock, implying an increase of about 7% from current levels. The 12-month price range currently stands between $335 and $561.

Similarly, according to a number of valuation models, like those that might consider P/E or P/S multiples, dividends or terminal values, the average fair value for ANTM stock via InvestingPro stands at $572.31.

ANTM Fair Value
ANTM Fair Value

Source: InvestingPro

In other words, fundamental valuation suggests shares could increase around 28%.

Meanwhile, we can look at Anthem’s financial health as determined by ranking more than 100 factors against peers in the healthcare sector. In terms of profit and price momentum, it scores 4 out of 5 (top score). But cash flow and growth stand at 3. Anthem's overall performance is rated great.”

At present, P/E, P/B and P/S ratios for ANTM stock are 19.7x, 3.0x and 0.8x. By comparison, those metrics for its peers stand at 10.5x, 1.4x and 0.7X. Meanwhile, comparable numbers for UnitedHealth Group Incorporated (NYSE:UNH)—covered here—are 28.2x, 6.2x and 1.6x.

As we have already noted, Anthem is expected to issue Q4 metrics next week. Therefore, in the coming days, we expect ANTM stock to be choppy, and possibly come under pressure. It could potentially slide toward $430, after which it should trade sideways, possibly between $420 and $440.

Adding ANTM Stock To Portfolios

Anthem bulls with a two- to three-year horizon who are not concerned about short-term volatility could consider buying into the declines. The target would be $479.21, which is the analysts' consensus expectation.

Alternatively, investors could consider buying an exchange traded fund (ETF) that has ANTM as a holding. Examples would include:

  • iShares U.S. Healthcare Providers ETF (NYSE:IHF)
  • Invesco S&P 500® Enhanced Value ETF (NYSE:SPVU)
  • T. Rowe Price Equity Income ETF (NYSE:TEQI)
  • First Trust Rising Dividend Achievers ETF (NASDAQ:RDVY)

Finally, those who are experienced with options strategies and believe there could be further declines in Anthem shares during this earnings season might prefer to do a bear put spread.

Most option strategies are not suitable for most retail investors. Therefore, the following discussion is offered for educational purposes and not as an actual strategy to be followed by the average retail investor.

Bear Put Spread On Anthem Stock

Intraday Price: $447.10

In a bear put spread, a trader has a long put with a higher strike price as well as a short put with a lower strike price. Both legs of the trade have the same underlying stock (i.e. Anthem here) and the same expiration date.

The trader wants ANTM stock to decline in price. However, in a bear put spread, both the potential profit and the potential loss levels are limited.

Here's an example:

For the first leg of this strategy, the trader might buy an at-the-money (ATM) or slightly out-of-the-money (OTM) put option, like the ANTM March 18, 2022, 440-strike put option. This option is currently offered at $18.10. It would cost the trader $1,810 to own this put option, which expires in less than two months.

For the second leg of this strategy, the trader sells a put, like the ANTM March 18, 2022, 430-strike put option. This options current premium is $14.20. The option seller would receive $1,420, excluding trading commissions.

Maximum Risk

In our example, the maximum risk will be equal to the cost of the spread plus commissions. Here, the net cost of the spread is $3.90 ($18.10 – $14.20 = $3.90).

As each option contract represents 100 shares of the underlying stock, wed need to multiply $3.90 by 100, which gives us $390 as the maximum risk.

The trader could easily lose this amount if the position is held to expiry and both legs expire worthless, i.e., if the Anthem stock price at expiration is above the strike price of the long put (or $440 in our example).

Maximum Profit Potential

In a bear put spread, potential profit is limited to the difference between the two strike prices minus the net cost of the spread plus commissions.

So in our example, the difference between the strike prices is $10 ($440 – $430 = $10). And as weve seen above, the net cost of the spread is $3.90.

The maximum profit, therefore, is $6.10 ($10.00 – $3.90 = $6.10) per share less commissions. When we multiply $6.10 by 100 shares, the maximum profit for this option strategy comes to $610.

The trader will realize this maximum profit if the price of ANTM stock is at or below the strike price of the short put (lower strike) at expiration (or $430 in our example).

Investors who have traded options before are likely to know that short put positions are typically assigned at expiration if the stock price is below the strike price (i.e., $430 here).

However, there is also the possibility of early assignment. Therefore, the position would need monitoring up until expiration.

Break-Even ANTM Price At Expiration

Finally, we should also calculate the break-even point for this trade. At that price, the trade will not gain or lose any money.

At expiration, the strike price of the long put (i.e., $440 in our example) minus the net premium paid (i.e., $3.90 here) would give us the break-even price.

In our example: $440 − $3.90 = $436.10 (minus commissions).

Bottom Line

Long-term shareholders in Anthem stock have seen excellent returns since the multi-year low hit in March 2020 at the start of the pandemic. The Street’s consensus rating for the new year is also bullish.

However, ANTM stock started 2022 on a down note. We can possibly expect the volatility in the share price to continue as Anthem gets ready to report Q4 earnings. Later in the year, however, shares of the health insurer should start a new leg higher.

3 Trades On Anthem Stock Ahead Of The Healthcare Giant's Q4 Report

Related Articles

3 Trades On Anthem Stock Ahead Of The Healthcare Giant's Q4 Report

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Sardar Abrar
Sardar Abrar Jan 19, 2022 15:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
plz information this app I don't know this app
som sithy
som sithy Jan 19, 2022 14:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
Sign up with Email